Skip to main content
Erschienen in:

07.12.2018 | Original paper

Evaluating centralized technical assistance as an implementation strategy to improve cancer prevention and control

verfasst von: Sarah Moreland-Russell, Prajakta Adsul, Seif Nasir, Maria E. Fernandez, Timothy J. Walker, Heather M. Brandt, Robin C. Vanderpool, Meagan Pilar, Paula Cuccaro, Wynne E. Norton, Cynthia A. Vinson, David A. Chambers, Ross C. Brownson

Erschienen in: Cancer Causes & Control | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In 2015–2016, the Comprehensive Cancer Control National Partnership provided technical assistance workshops to support 22 cancer coalitions in increasing human papillomavirus (HPV) vaccination uptake and increasing colorectal cancer (CRC) screening in their local communities. As national efforts continue to invest in providing technical assistance, there is a current gap in understanding its use as a strategy to accelerate implementation of evidence-based interventions (EBIs) for cancer prevention. The objective of this study was to evaluate the impact of technical assistance on the participants’ knowledge, attitudes, and skills for implementing EBIs in their local context and enhancing state team collaboration.

Methods

Data were collected August-November 2017 using web-based questionnaires from 44 HPV workshop participants and 66 CRC workshop participants.

Results

Both HPV vaccination and CRC screening workshop participants reported changes in knowledge, attitudes, and skills related to implementing EBIs in their local state context. Several participants reported increased abilities in communicating and coordinating with partners in their states and utilizing additional implementation strategies to increase HPV vaccination uptake and CRC screening rates.

Conclusions

Findings from this study suggest that providing technical assistance to members of comprehensive cancer control coalitions is useful in promoting collaborations and building capacity for implementing EBIs for cancer prevention and control.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Singer DS, Jacks T, Jaffee E (2016) “A US “Cancer Moonshot” to accelerate cancer research. Science 353(6304):1105–1106CrossRef Singer DS, Jacks T, Jaffee E (2016) “A US “Cancer Moonshot” to accelerate cancer research. Science 353(6304):1105–1106CrossRef
3.
Zurück zum Zitat Rimer B, Harper H, Witte O (2014) Accelerating HPV vaccine uptake: urgency for action to prevent cancer; a report to the President of the United States from the President’s Cancer Panel. National Cancer Institute, Bethesda Rimer B, Harper H, Witte O (2014) Accelerating HPV vaccine uptake: urgency for action to prevent cancer; a report to the President of the United States from the President’s Cancer Panel. National Cancer Institute, Bethesda
6.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC) (2013) Vital signs: colorectal cancer screening test use–United States, 2012. MMWR Morb Mortal Wkly Rep 62(44):881–888 Centers for Disease Control and Prevention (CDC) (2013) Vital signs: colorectal cancer screening test use–United States, 2012. MMWR Morb Mortal Wkly Rep 62(44):881–888
7.
Zurück zum Zitat Honein-AbouHaidar GN, Kastner M, Vuong V, Perrier L, Daly C, Rabeneck L, Straus S, Baxter NN (2016) Systematic review and meta-study synthesis of qualitative studies evaluating facilitators and barriers to participation in colorectal cancer screening. Cancer Epidemiology and Prevention Biomarkers Honein-AbouHaidar GN, Kastner M, Vuong V, Perrier L, Daly C, Rabeneck L, Straus S, Baxter NN (2016) Systematic review and meta-study synthesis of qualitative studies evaluating facilitators and barriers to participation in colorectal cancer screening. Cancer Epidemiology and Prevention Biomarkers
8.
Zurück zum Zitat Paskett ED, Khuri FR (2015) Can we achieve an 80% screening rate for colorectal cancer by 2018 in the United States? Cancer 121(13):2127–2128CrossRef Paskett ED, Khuri FR (2015) Can we achieve an 80% screening rate for colorectal cancer by 2018 in the United States? Cancer 121(13):2127–2128CrossRef
9.
Zurück zum Zitat Eccles MP, Mittman BS (2006) Welcome to implementation science. Implement Sci 1(1):1CrossRef Eccles MP, Mittman BS (2006) Welcome to implementation science. Implement Sci 1(1):1CrossRef
11.
Zurück zum Zitat Hohman K, Rochester P, Kean T, Belle-Isle L (2010) The CCC National Partnership: an example of organizations collaborating on comprehensive cancer control. Cancer Causes Control 21(12):1979–1985CrossRef Hohman K, Rochester P, Kean T, Belle-Isle L (2010) The CCC National Partnership: an example of organizations collaborating on comprehensive cancer control. Cancer Causes Control 21(12):1979–1985CrossRef
12.
Zurück zum Zitat Given LS, Black B, Lowry G, Huang P, Kerner JF (2005) Collaborating to conquer cancer: a comprehensive approach to cancer control. Cancer Causes Control 16(1):3–14CrossRef Given LS, Black B, Lowry G, Huang P, Kerner JF (2005) Collaborating to conquer cancer: a comprehensive approach to cancer control. Cancer Causes Control 16(1):3–14CrossRef
13.
Zurück zum Zitat Roundtable NCC (2014) Steps for increasing colorectal cancer screening rates: a manual for community health centers Roundtable NCC (2014) Steps for increasing colorectal cancer screening rates: a manual for community health centers
14.
Zurück zum Zitat Wandersman A, Chien VH, Katz J (2012) Toward an evidence-based system for innovation support for implementing innovations with quality: tools, training, technical assistance, and quality assurance/quality improvement. Am J Community Psychol 50(3–4):445–459CrossRef Wandersman A, Chien VH, Katz J (2012) Toward an evidence-based system for innovation support for implementing innovations with quality: tools, training, technical assistance, and quality assurance/quality improvement. Am J Community Psychol 50(3–4):445–459CrossRef
15.
Zurück zum Zitat Stetler CB, Legro MW, Rycroft-Malone J, Bowman C, Curran G, Guihan M, Hagedorn H, Pineros S, Wallace CM (2006) Role of” external facilitation” in implementation of research findings: a qualitative evaluation of facilitation experiences in the Veterans Health Administration. Implement Sci 1(1):23CrossRef Stetler CB, Legro MW, Rycroft-Malone J, Bowman C, Curran G, Guihan M, Hagedorn H, Pineros S, Wallace CM (2006) Role of” external facilitation” in implementation of research findings: a qualitative evaluation of facilitation experiences in the Veterans Health Administration. Implement Sci 1(1):23CrossRef
16.
Zurück zum Zitat Cranley LA et al (2017) Facilitation roles and characteristics associated with research use by healthcare professionals: a scoping review. BMJ Open 7(8):e014384CrossRef Cranley LA et al (2017) Facilitation roles and characteristics associated with research use by healthcare professionals: a scoping review. BMJ Open 7(8):e014384CrossRef
17.
Zurück zum Zitat Snow J, Mann M (2013) Qualtrics survey software: handbook for research professionals. Qualtrics Labs Inc., Provo Snow J, Mann M (2013) Qualtrics survey software: handbook for research professionals. Qualtrics Labs Inc., Provo
18.
Zurück zum Zitat Neuendorf KA (2016) The content analysis guidebook. Sage, Los Angeles Neuendorf KA (2016) The content analysis guidebook. Sage, Los Angeles
20.
Zurück zum Zitat Steele CB, Rose JM, Chovnick G, Townsend MJS, Stockmyer MCK, Fonseka MJ, Richardson LC (2015) Use of evidence-based practices and resources among comprehensive cancer control programs. J Public Health Manag Pract 21(5):441CrossRef Steele CB, Rose JM, Chovnick G, Townsend MJS, Stockmyer MCK, Fonseka MJ, Richardson LC (2015) Use of evidence-based practices and resources among comprehensive cancer control programs. J Public Health Manag Pract 21(5):441CrossRef
21.
Zurück zum Zitat Townsend JS, Richardson LC, Steele CB, White DE (2009) Evidence-based interventions and screening recommendations for colorectal cancer in comprehensive cancer control plans: a content analysis. Prev Chronic Dis 6(4):A127PubMedPubMedCentral Townsend JS, Richardson LC, Steele CB, White DE (2009) Evidence-based interventions and screening recommendations for colorectal cancer in comprehensive cancer control plans: a content analysis. Prev Chronic Dis 6(4):A127PubMedPubMedCentral
22.
Zurück zum Zitat Townsend JS, Steele CB, Hayes N, Bhatt A, Moore AR (2017) Human papillomavirus vaccine as an anticancer vaccine: collaborative efforts to promote human papillomavirus vaccine in the national comprehensive cancer control program. J Womens Health (Larchmt) 26(3):200–206. https://doi.org/10.1089/jwh.2017.6351 CrossRef Townsend JS, Steele CB, Hayes N, Bhatt A, Moore AR (2017) Human papillomavirus vaccine as an anticancer vaccine: collaborative efforts to promote human papillomavirus vaccine in the national comprehensive cancer control program. J Womens Health (Larchmt) 26(3):200–206. https://​doi.​org/​10.​1089/​jwh.​2017.​6351 CrossRef
24.
Zurück zum Zitat Given LS, Hohman K, Graaf L, Rochester P, Belle-Isle L (2010) From planning to implementation to outcomes: comprehensive cancer control implementation building blocks. Cancer Causes Control 21(12):1987–1994CrossRef Given LS, Hohman K, Graaf L, Rochester P, Belle-Isle L (2010) From planning to implementation to outcomes: comprehensive cancer control implementation building blocks. Cancer Causes Control 21(12):1987–1994CrossRef
26.
Zurück zum Zitat Leeman J, Calancie L, Hartman MA, Escoffery CT, Herrmann AK, Tague LE, Moore AA, Wilson KM, Schreiner M, Samuel-Hodge C (2015) What strategies are used to build practitioners’ capacity to implement community-based interventions and are they effective?: a systematic review. Implement Sci 10(1):80CrossRef Leeman J, Calancie L, Hartman MA, Escoffery CT, Herrmann AK, Tague LE, Moore AA, Wilson KM, Schreiner M, Samuel-Hodge C (2015) What strategies are used to build practitioners’ capacity to implement community-based interventions and are they effective?: a systematic review. Implement Sci 10(1):80CrossRef
27.
Zurück zum Zitat Cranley LA, Cummings GG, Profetto-McGrath J, Toth F, Estabrooks CA (2017) Facilitation roles and characteristics associated with research use by healthcare professionals: a scoping review. BMJ Open 7(8):e014384CrossRef Cranley LA, Cummings GG, Profetto-McGrath J, Toth F, Estabrooks CA (2017) Facilitation roles and characteristics associated with research use by healthcare professionals: a scoping review. BMJ Open 7(8):e014384CrossRef
Metadaten
Titel
Evaluating centralized technical assistance as an implementation strategy to improve cancer prevention and control
verfasst von
Sarah Moreland-Russell
Prajakta Adsul
Seif Nasir
Maria E. Fernandez
Timothy J. Walker
Heather M. Brandt
Robin C. Vanderpool
Meagan Pilar
Paula Cuccaro
Wynne E. Norton
Cynthia A. Vinson
David A. Chambers
Ross C. Brownson
Publikationsdatum
07.12.2018
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 12/2018
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-018-1108-y

Neu im Fachgebiet Onkologie

Polypen bei nahen Verwandten – erhöhtes Darmkrebsrisiko

Werden bei erstgradigen Verwandten gutartige Darmpolypen identifiziert, ist das Risiko, selbst an einem Kolorektalkarzinom zu erkranken, deutlich erhöht – vor allem das für eine früh beginnende Erkrankung. Hier könnte sich eine frühe Koloskopie besonders lohnen.

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

Welche Krebserkrankungen bei Zöliakie häufiger auftreten

Eine große Kohortenstudie hat den Zusammenhang zwischen Zöliakie und gastrointestinalen Krebserkrankungen und inflammatorischen Krankheiten untersucht. Neben gastrointestinalen Tumoren ist auch ein nicht solider Krebs häufiger.

Adjuvanter PD-L1-Hemmer verhindert Rezidive bei Hochrisiko-Urothelkarzinom

Sind Menschen mit muskelinvasivem Urothelkarzinom für die neoadjuvante platinbasierte Therapie nicht geeignet oder sprechen sie darauf nicht gut an, ist Pembrolizumab eine adjuvante Alternative: Die krankheitsfreie Lebenszeit wird dadurch mehr als verdoppelt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.